Home : Unsafe Drugs : Zelnorm
Zelnorm
Zelnorm (tegaserod maleate) is a drug used in the treatment of irritable bowel syndrome (IBS) and manufactured by Novartis. It was approved for short-term treatment of constipation in IBS-affected women and for chronic constipation in patients 65 years and younger. In 2007, Zelnorm was found to cause an increased risk of stroke and heart attacks in patients and Novartis, at the urging of the federal Food and Drug Administration (FDA), withdrew Zelnorm from the market in the United States.
Fast Facts
| Name: | Zelnorm |
| Generic: | Tegaserod maleate |
| Manufacturer: | Novartis |
| Date approved: | 2002 |
| Status: | Voluntarily withdrawn from market in United States upon request of the federal Food and Drug Administration (FDA) |
| Approved uses: | Short-term treatment of chronic constipation in women with irritable bowel syndrome (IBS); treatment of chronic constipation in patients age 65 and under. |
| Off-Label uses: | Treatment of IBS in men; treatment of idiopathic constipation in patients over 65 years of age |
| Side effects: | Zelnorm has been linked with a higher chance of stroke, heart attack, and chest pain in some patients. Other Zelnorm side effects include abdominal pain, diarrhea and headache. |
| Related topics: | Strattera, Tequin |
Novartis Recalls IBS Drug Zelnorm
It was hailed as a breakthrough treatment for irritable bowel syndrome (IBS) and constipation. Its ad campaign ran prominently on TV and in the national press. But Zelnorm, the IBS drug produced by... read more
Zelnorm Side Effects: Know the Risks
With recent news that Zelnorm, Novartis' "breakthrough" drug for the treatment of IBS (irritable bowel syndrome), has been taken off of store shelves due to safety concerns, you might be... read more
View the Zelnorm Main Articles page here
FDA Information Related to Zelnorm
March 2007 Monthly Safety Labeling Changes
FDA Permits Restricted Use of Zelnorm for Qualifying Patients
View the Zelnorm FDA Information page here
MSN Newsfeeds Related to Zelnorm
Novartis Profit Declines on Lost Sales to Generics (Update10)
Novartis: Latest Victim Of U.S. Economy
View the Zelnorm MSN Newsfeeds page here
News Articles Related to Zelnorm
View the Zelnorm News Articles page here
Useful Web Sites Related to Zelnorm
Anapol Schwartz Lawyers - Pennsylvania Zelnorm Lawsuits
View the Zelnorm Useful Web Sites page here
Wikipedia Entries Related to Zelnorm
View the Zelnorm Wikipedia Entries page here
Books Related to Zelnorm
New & approved: Zelnorm * Xyrem.: An article from: Internal Medicine News
View the Zelnorm Books page here
